B
Bradley H. Strauss
Researcher at Sunnybrook Health Sciences Centre
Publications - 226
Citations - 10255
Bradley H. Strauss is an academic researcher from Sunnybrook Health Sciences Centre. The author has contributed to research in topics: Restenosis & Percutaneous coronary intervention. The author has an hindex of 50, co-authored 218 publications receiving 9595 citations. Previous affiliations of Bradley H. Strauss include Heart and Stroke Foundation of Canada & University of Toronto.
Papers
More filters
Journal ArticleDOI
Angiographic follow-up after placement of a self-expanding coronary-artery stent.
Patrick W. Serruys,Bradley H. Strauss,Kevin J. Beatt,Michel E. Bertrand,Jacques Puel,Anthony F. Rickards,Bernhard Meier,Jean-Jacques Goy,Pierre Vogt,Lukas Kappenberger,Ulrich Sigwart +10 more
TL;DR: Early occlusion remains an important limitation of this coronary-artery stent and even when the early effects are beneficial, there are frequently late occlusions or restenosis.
Journal ArticleDOI
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial.
Patrick W. Serruys,Pim J. de Feyter,Carlos Macaya,Norbert Kokott,Jacques Puel,Matthias Vrolix,Angelo Branzi,M. C. Bertolami,Graham Jackson,Bradley H. Strauss,Bernhard Meier +10 more
TL;DR: Fuvastatin treatment in patients with average cholesterol levels undergoing their first successful PCI significantly reduces the risk of major adverse cardiac events.
Journal ArticleDOI
Current Perspectives on Coronary Chronic Total Occlusions: The Canadian Multicenter Chronic Total Occlusions Registry
Paul Fefer,Paul Fefer,Merril L. Knudtson,Asim N. Cheema,P. Diane Galbraith,Azriel B. Osherov,Sergey Yalonetsky,Sharon Gannot,Michelle Samuel,Max Weisbrod,Daniel Bierstone,John D. Sparkes,Graham A. Wright,Bradley H. Strauss +13 more
TL;DR: Chronic total occlusions are common in contemporary catheterization laboratory practice and Prospective studies are needed to ascertain the benefits of treatment strategies of these complex patients.
Journal ArticleDOI
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II.
Gregg W. Stone,David E. Kandzari,Roxana Mehran,Antonio Colombo,Robert S. Schwartz,Steven R. Bailey,Issam Moussa,Paul S. Teirstein,George Dangas,Donald S. Baim,Matthew Selmon,Bradley H. Strauss,Hideo Tamai,Takahiko Suzuki,Kazuaki Mitsudo,Osamu Katoh,David A. Cox,Angela Hoye,Gary S. Mintz,Eberhard Grube,Louis Cannon,Nicolaus Reifart,Mark Reisman,Alexander Abizaid,Jeffrey W. Moses,Martin B. Leon,Patrick W. Serruys +26 more
TL;DR: The technical approach to and outcomes after percutaneous coronary intervention (PCI) of occluded coronary arteries, as well as the novel devices and drugs approved and undergoing investigation for CTO recanalization, are summarized.
Journal ArticleDOI
Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation.
Paul W.M. Fedak,Mauro P.L. de Sa,Subodh Verma,Nafiseh Nili,Pedram Kazemian,Jagdish Butany,Bradley H. Strauss,Richard D. Weisel,Tirone E. David +8 more
TL;DR: Deficient fibrillin-1 content in the vasculature of patients with bicuspid aortic valves might trigger matrix metalloproteinase production, leading to matrix disruption and dilatation in this disease.